A quiet but powerful process begins the moment food touches your mouth. Long before your immune system reacts, bacteria in ...

The pollen is back – but that doesn't mean you should stop running. We explain the symptoms of hay fever and how to relieve ...

Thank you for signing up! Did you know with an ad-lite subscription to Northampton Chronicle and Echo, you get 70% fewer ads ...

Goldman Sachs 9th Annual Biopharma Innovation Summit March 26, 2026 5:00 AM EDTCompany ParticipantsKaivan Khavandi - Senior VP, Global Head ...

Boarding a flight usually involves scanning your ticket, stowing your carry‑on, and settling in with the hope of a smooth journey ahead. But for some travelers, there’s another layer of preparation: ...

The University of Notre Dame will celebrate 20 years of its "What Would You Fight For?" series with panel discussion at 4 p.m ...

A combination of dry, windy and hot weather is shaping up to make for a miserable spring allergy season in the Bay Area. The National Allergy Bureau found high levels of tree pollen in San Jose, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has already approved remibrutinib for chronic spontaneous urticaria. This phase 2 study demonstrates ...

Younger siblings of peanut-consuming children have an increased risk for peanut sensitization and allergy, which can be mitigated by early introduction of peanuts, according to a study presented at ...

AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed allergy ...

PHILADELPHIA -- Oral remibrutinib (Rhapsido) increased peanut tolerance in adults with proven allergy to it, with benefits in as little as 1 week, a phase II trial showed. After 4 weeks on the ...